Authors:
GARDNER A
XU FH
FADY C
SARAFIAN T
TU YP
LICHTENSTEIN A
Citation: A. Gardner et al., EVIDENCE AGAINST THE HYPOTHESIS THAT BCL-2 INHIBITS APOPTOSIS THROUGHAN ANTIOXIDANT EFFECT, Cell death and differentiation, 4(6), 1997, pp. 487-496
Citation: Kb. Briskin et al., APOPTOTIC INHIBITION OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA-CELLS BY TUMOR-NECROSIS-FACTOR-ALPHA, Archives of otolaryngology, head & neck surgery, 122(5), 1996, pp. 559-563
Authors:
TU YP
XU FH
LIU J
VESCIO R
BERENSON J
FADY C
LICHTENSTEIN A
Citation: Yp. Tu et al., UP-REGULATED EXPRESSION OF BCL-2 IN MULTIPLE-MYELOMA CELLS INDUCED BYEXPOSURE TO DOXORUBICIN, ETOPOSIDE, AND HYDROGEN-PEROXIDE, Blood, 88(5), 1996, pp. 1805-1812
Authors:
FADY C
GARDNER A
JACOBY F
BRISKIN K
TU YP
SCHMID I
LICHTENSTEIN A
Citation: C. Fady et al., ATYPICAL APOPTOTIC CELL-DEATH INDUCED IN L929 TARGETS BY EXPOSURE TO TUMOR-NECROSIS-FACTOR, Journal of interferon & cytokine research, 15(1), 1995, pp. 71-80
Authors:
BRISKIN KB
FADY C
MICKEL RA
WANG M
LICHTENSTEIN A
Citation: Kb. Briskin et al., INHIBITION OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA CELL-LINES BY TRANSFORMING GROWTH-FACTOR-BETA, Otolaryngology and head and neck surgery, 112(6), 1995, pp. 728-734
Citation: C. Fady et al., INTERFERON-GAMMA-INDUCED INCREASED SENSITIVITY OF HER2 NEU-OVEREXPRESSING TUMOR-CELLS TO LYMPHOKINE-ACTIVATED KILLER-CELL LYSIS - IMPORTANCE OF ICAM-1 IN BINDING AND POST-BINDING EVENTS/, Cancer immunology and immunotherapy, 37(5), 1993, pp. 329-336
Authors:
GERA JF
FADY C
GARDNER A
JACOBY FJ
BRISKIN KB
LICHTENSTEIN A
Citation: Jf. Gera et al., INHIBITION OF DNA-REPAIR WITH APHIDICOLIN ENHANCES SENSITIVITY OF TARGETS TO TUMOR-NECROSIS-FACTOR, The Journal of immunology, 151(7), 1993, pp. 3746-3757